Search

everythinglearnresearchcommunity

for

Search:↓

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Four herbal extracts in a liposomal formulation can help prevent hair loss.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Liposomes can safely and effectively deliver substances to mouse hair follicles, potentially useful for human hair treatments.

Cationic polymers improved liposome stability and increased skin absorption of aciclovir and minoxidil.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Targeting hair follicles can improve skin treatments and reduce side effects.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

LCN may improve finasteride delivery for hair loss treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.